Latest Breaking News On - News ratings for tarsus pharmaceuticals daily - Page 2 : comparemela.com

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61 00

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAziz mottiwalaSeshadri neervannanFinancial servicesProshare advisorsNews ratings for tarsus pharmaceuticals dailyTarsus pharmaceuticals incTarsus pharmaceuticals company profileAnalyst recommendations for tarsus pharmaceuticalsGoldman sachs groupBleakley financial groupSecurities exchange commissionLord abbettTarsus pharmaceuticals stock performanceTarsus pharmaceuticalsInstitutional trading of tarsus pharmaceuticals

Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) Stake Decreased by Vivo Capital LLC

Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) Stake Decreased by Vivo Capital LLC
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankSeshadri neervannanBryan wahlMirae asset global investments coTarsus pharmaceuticals incHoldings channelGoldman sachs groupTarsus pharmaceuticals stock performanceNews ratings for tarsus pharmaceuticals dailyTarsus pharmaceuticals profileJefferies financial groupChina universal asset management coVivo capitalQuarter for tarsus pharmaceuticalsRaymond james associates

Tarsus Pharmaceuticals (NASDAQ:TARS) PT Raised to $61 00

Tarsus Pharmaceuticals (NASDAQ:TARS) PT Raised to $61 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankSeshadri neervannanBryan wahlHedge funds weigh in on tarsus pharmaceuticalsAnalyst recommendations for tarsus pharmaceuticalsTarsus pharmaceuticals incTarsus pharmaceuticals stock downNews ratings for tarsus pharmaceuticals dailyRaymond james associatesIeq capitalChina universal asset management coGoldman sachs groupTower research capitalJefferies financial groupTarsus pharmaceuticals

Vivo Capital LLC Has $36 13 Million Holdings in Tarsus Pharmaceuticals, Inc (NASDAQ:TARS)

Vivo Capital LLC Has $36 13 Million Holdings in Tarsus Pharmaceuticals, Inc (NASDAQ:TARS)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesBryan wahlAziz mottiwalaZurcher kantonalbank zurich cantonalbankTarsus pharmaceuticals stock downMirae asset global investments coGoldman sachs groupTarsus pharmaceuticals incNews ratings for tarsus pharmaceuticals dailySecurities exchange commissionChina universal asset management coJefferies financial groupVivo capitalQuarter for tarsus pharmaceuticalsRaymond james associatesIeq capital

abrdn plc Purchases New Holdings in Tarsus Pharmaceuticals, Inc (NASDAQ:TARS)

abrdn plc acquired a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 72,032 shares of the company’s stock, valued at approximately $1,459,000. abrdn plc owned approximately 0.22% of Tarsus Pharmaceuticals as of […]

United statesBobakr azamianAziz mottiwalaZurcher kantonalbank zurich cantonalbankTarsus pharmaceuticals incTarsus pharmaceuticals company profileSecurities exchange commissionMirae asset global investments coTarsus pharmaceuticals stockQuarter for tarsus pharmaceuticalsNews ratings for tarsus pharmaceuticals dailyRaymond james associatesTarsus pharmaceuticalsGoldman sachs groupIeq capitalExchange commission